发明名称 |
Novel NIDDM regimen |
摘要 |
The present invention relates to the use of a short-acting oral hypoglycemic agent and to a novel regimen in the treatment of type 2 diabetes in which the endogenous secretion of insulin is stimulated in connection with meals by administering in connection with the meals a short-acting oral hypoglycaemic agent. Also, the present invention relates to a method of achieving significantly improvement in the glycaemic control by a combined use of repaglinide and metformin in NIDDM patients poorly controlled on metformin alone.
|
申请公布号 |
US2004176457(A1) |
申请公布日期 |
2004.09.09 |
申请号 |
US20030376357 |
申请日期 |
2003.02.27 |
申请人 |
HEMMINGSEN LISBETH TOFTE;MULLER PETER GIORTZ |
发明人 |
HEMMINGSEN LISBETH TOFTE;MULLER PETER GIORTZ |
分类号 |
A61K31/155;A61K31/198;(IPC1-7):A61K31/198 |
主分类号 |
A61K31/155 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|